Origins of atrophy in Parkinson linked to early onset and local transcription patterns.
Pedro D MaiaSneha PandyaBenjamin FreezeJustin TorokAjay GuptaYashar ZeighamiAshish RajPublished in: Brain communications (2020)
There is enormous clinical value in inferring the brain regions initially atrophied in Parkinson disease for individual patients and understanding its relationship with clinical and genetic risk factors. The aim of this study is to leverage a new seed-inference algorithm demonstrated for Alzheimer's disease to the Parkinsonian context and to cluster patients in meaningful subgroups based on these incipient atrophy patterns. Instead of testing brain regions separately as the likely initiation site for each patient, we solve an L1-penalized optimization problem that can return a more predictive heterogeneous, multi-locus seed patterns. A cluster analysis of the individual seed patterns reveals two distinct subgroups (S1 versus S2). The S1 subgroup is characterized by the involvement of the brainstem and ventral nuclei, and S2 by cortex and striatum. Post hoc analysis in features not included in the clustering shows significant differences between subgroups regarding age of onset and local transcriptional patterns of Parkinson-related genes. Top genes associated with regional microglial abundance are strongly associated with subgroup S1 but not with S2. Our results suggest two distinct aetiological mechanisms operative in Parkinson disease. The interplay between immune-related genes, lysosomal genes, microglial abundance and atrophy initiation sites may explain why the age of onset for patients in S1 is on average 4.5 years later than for those in S2. We highlight and compare the most prominently affected brain regions for both subgroups. Altogether, our findings may improve current screening strategies for early Parkinson onsetters.
Keyphrases
- parkinson disease
- end stage renal disease
- early onset
- ejection fraction
- newly diagnosed
- chronic kidney disease
- risk factors
- deep brain stimulation
- randomized controlled trial
- white matter
- clinical trial
- resting state
- peritoneal dialysis
- functional connectivity
- late onset
- machine learning
- spinal cord injury
- case report
- genome wide
- patient reported
- brain injury
- blood brain barrier
- mild cognitive impairment
- antibiotic resistance genes